Cytogen, Inc. announced a private placement to issue common shares for the gross proceeds of up to KRW 99,999,821,616 on December 28, 2023. The transaction will include participation from returning investor, Candx Holdings Limited for 7,120,726 at ratio of 31.96% and individual investors such as Jeon Byeong-hee for 3,345,271 shares at ratio of 15.02% and Go Byeong-cheon for 43,050 shares at ratio of 0.19%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9,770 KRW | +4.16% | -2.69% | -27.74% |
1st Jan change | Capi. | |
---|---|---|
-27.74% | 153M | |
+15.30% | 3.43B | |
+2.34% | 2.27B | |
-19.52% | 2.03B | |
-20.72% | 1.63B | |
+31.45% | 1.16B | |
+21.58% | 714M | |
-9.39% | 703M | |
-21.63% | 500M | |
-1.29% | 279M |
- Stock Market
- Equities
- A217330 Stock
- News Cytogen, Inc.
- Cytogen, Inc. announced that it expects to receive KRW 99.999821616 billion in funding from Candx Holdings Limited